|
HS Code |
854281 |
| Product Name | 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid |
| Molecular Formula | C8H6BrFO3 |
| Molecular Weight | 247.03 g/mol |
| Cas Number | 886380-34-5 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Melting Point | 135-139°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Smiles | COC1=C(C=C(C=C1F)Br)C(=O)O |
| Inchi | InChI=1S/C8H6BrFO3/c1-13-7-3-4(8(11)12)2-6(10)5(7)9/h2-3H,1H3,(H,11,12) |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Synonyms | 2-Fluoro-3-methoxy-4-bromobenzoic acid |
As an accredited 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Labs and production lines often rely on small tweaks in molecular structure to dig up new possibilities. 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid stands out as an example of how a single compound can open new avenues in pharmaceutical and specialty chemical research. Its structure—layered with bromine, fluorine, and methoxy groups on a benzoic acid core—offers more than just another lab chemical. As someone who’s worked both in academic labs and the process optimization side of the industry, I’ve seen such molecules provide tangible advantages over their close chemical cousins.
Add a bromo group here, swap in a fluorine there—chemists know that’s how you nudge reactivity, solubility, and selectivity. This compound’s formula places a bromine atom at the para position, a fluorine in the ortho slot, and a methoxy crowding the meta site relative to the carboxylic acid. This pattern shapes its behavior in cross-coupling, aromatic substitution, and other transformations that drive modern medicinal chemistry. Fluorine’s presence often changes metabolic stability and can deepen binding interactions in drug leads. Methoxy brings electron-donating power, which tilts the reactivity, and bromine takes center stage in Suzuki or Buchwald-Hartwig couplings. This precise arrangement is rare. Many benzoic acids carry only one or two substituents; here, the triple combination widens what’s possible in a synthetic route.
Take a tour through patents on kinase inhibitors or new agrochemicals, and you’ll see a recurring trick: insert a carefully decorated benzoic acid and watch properties change. Whether feeding a Suzuki reaction on a high-throughput robot or scaling up batches for animal testing, small efficiency gains pile up. Compounds like 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid let chemists attach, swap, or extend molecular arms at specific locations on the ring—without tiresome protection and deprotection steps. This not only speeds discovery, but it cuts down on waste. Less time and fewer hazardous reagents are spent in the pursuit of a final molecule.
The combination of fluorine and methoxy is not for show. In the right structure, this pairing can dodge oxidative metabolism in human or animal systems, letting new drug candidates stay active longer. Meanwhile, bromine’s bulkiness and reactivity serve as handles for building up libraries of analogs. This flexibility benefits large pharma, custom synthesis firms, and university researchers alike.
Consider the baseline options: plain benzoic acid, or those with only bromo or methoxy substituents. Plain benzoic acid offers a blank canvas but doesn’t provide the specificity required for fine-tuned SAR (structure-activity relationship) studies. Adding only a bromine or methoxy group can help with reactivity, but falls flat in terms of selectivity or downstream modifications. I’ve found that traditional halogenated benzoic acids (like 4-bromobenzoic acid) often lack the ability to be pushed selectively in more advanced cross-coupling reactions. You wind up with off-target substitutions or by-products that complicate purification. In contrast, the added methoxy and fluorine on this compound lock in reactivity just enough to help the desired reaction stand out—much like a precision tool in a cluttered toolbox.
There’s something more than the sum of the parts here. Fluoro- and methoxy-substituted aromatics play central roles in bioactivity, often improving cell penetration, target affinity, or environmental persistence. In environmental chemistry, for example, tweaking the electronics of a benzoic acid core guides how a molecule breaks down in soil or water, helping researchers select for compounds that last just long enough without leaching into the ecosystem.
Organic research doesn’t unfold in isolation. Academic chemists run benchtop reactions to make probes, intermediates, or reference standards; R&D specialists in pharma take similar intermediates and flow them into pipelines for safety, toxicity, and efficacy testing. Even contract manufacturers receive blueprints—demanding specialized building blocks that hold up under strict regulatory oversight. In this world, quality and consistency rule. Every batch of 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid must meet rigorous tests for melting point, purity (usually >98% by HPLC or NMR), and moisture content.
Anecdotally, colleagues using generic halogenated benzoic acids often wrestled with solubility issues, residue after solvent evaporation, or surprises during upscaling. The 3-methoxy group, though small, increases solubility in most polar aprotic solvents. That means less wrestling with sticky residues after a work-up. The bromo and fluoro combo improves both selectivity in metal-catalyzed couplings and the shelf stability—even after extended bench storage or wintertime shipping.
In real-world labs, supply chain and scalability matter just as much as reactivity. Standard intermediates sometimes fail halfway through scale-up, stalling projects and wasting hours on lost syntheses. Documented stability and predictable handling mean 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid rarely brings surprises. You can store it under ambient conditions in sealed bottles without degradation. Powder purity holds even after repeated sampling, thanks to its crystalline nature and limited hygroscopicity.
If you’ve ever worked on a development timeline, you know the headache that comes with batch variability. One shipment tests at high purity; the next, riddled with unidentified peaks by HPLC. This isn’t about theoretical trends—it’s the difference between a full week running analytical methods versus getting right to product formulation. Consistent lot quality in this compound means less troubleshooting and better predictability across the team, from chemists to formulators to analytical staff.
Chemical structure, supply chain resilience, and handling properties all matter to innovation. Modern synthesis isn’t about brute-forcing through a reaction until something works; it’s about planning for both short- and long-term suitability. With each substitution pattern, you invest in future cycles—adaptability in the face of new data or regulatory change. Every new molecule entering the synthesis chain is a reflection of current research priorities, safety standards, and market trends.
At one point, I sat through months of back-and-forth in a process chemistry group, aiming to swap older halogenated aromatics with more robust, modern building blocks. Issues crept up with every corner cut: variable melting points, inconsistent yields, even downstream problems with solubility in final formulations. With 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid, these issues largely faded. The well-defined reactivity, high shelf-stability, and solubility profile cut down the trial and error. That isn’t just a talking point—it means savings in labor, solvents, and analytical troubleshooting.
Conversations about synthetic intermediates often pivot to environmental and health impacts. Traditional halogenated aromatics sometimes carry persistent organic pollutant labels or complicated disposal requirements. Multi-functionalized compounds like 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid ride a finer line. The inclusion of fluorine and methoxy groups can adjust not only the performance of final molecules but also their breakdown rates and the complexity of waste management. In practice, modern waste treatment protocols and on-site incineration offer workable solutions, especially for relatively small batch intermediates.
On a personal level, I’ve found that strategizing with such building blocks can reduce overall environmental footprint. Fewer steps on the synthesis path mean less solvent waste, lower chances of hazardous byproducts, and more direct purification protocols. This checks boxes not only for compliance but for the growing focus on green chemistry.
Medicinal chemists spend significant hours mapping out how slight shifts in a benzoic acid core shape downstream bioactivity. With the right substituents, labs can tune parameters such as permeability, metabolic half-life, or binding specificity—sometimes using fewer iterations thanks to privileged structures. In my experience, many candidate drugs hit early roadblocks in development because their intermediates lacked this degree of tunability. 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid offers a shortcut to fine adjustments, letting chemists probe how each new analog tweaks a disease target or environmental outcome without the overhead of extra synthetic work.
You rarely get a single-reactive-site aromatic that also brings in the electronic push-pull of methoxy and fluoro groups. This unique balance lets researchers optimize binding or functionalization on the fly, especially during hit-to-lead or lead optimization campaigns in drug discovery.
While drug research dominates the conversation, I’ve seen applications pop up in agrochemical development, pigment formulation, and materials science. The structure brings just enough complexity to play a role as a cross-linking agent, surface modifier, or precursor to smart materials. For example, substituent patterns like this can offer control over light absorption in sensors, or help devise new classes of corrosion inhibitors for specialty polymers.
The reality is, every innovation in materials or life sciences rests on early choices in starting materials. Using a versatile intermediate like this one doesn’t just help one sector—it supports a pipeline of next-generation products for coatings, diagnostics, and smart packaging.
It’s tempting to reach for what’s already on hand, especially if deadlines loom or budgets run thin. Yet purpose-built intermediates like 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid have proven their worth in the long game—streamlining synthesis, reducing environmental liabilities, and improving the odds of meaningful innovation. The chemical industry increasingly demands forward-thinking, both to meet stricter regulatory standards and to chase efficiency gains across global operations. Integration of more precisely tuned aromatics at the synthesis stage pays dividends at every step of R&D, scale-up, and commercialization.
For researchers in demanding environments, where one synthetic hiccup can set back months of effort, reliability counts. My own transition from more generic benzoic acids to specialty intermediates brought better predictability and fewer headaches, especially at the analytical scale-up stage. Direct feedback from project timelines shows improved yields, clearer routes for impurity isolation, and easier product tracking through regulatory documentation.
Every day in the lab or plant puts a spotlight on the value of specialized building blocks. As industries move toward sustainable, tailor-made solutions, the focus drifts away from broad, one-size-fits-all intermediates to those that deliver a concrete edge at every step. Compounds like 4-Bromo-2-Fluoro-3-Methoxybenzoic Acid mark this turning point—not just as another entry in a catalog, but as a linchpin for smarter, safer, and more efficient chemistry.
Bringing these insights together points to an important shift. Strategic selection of chemical intermediates no longer relies solely on availability or price. It’s about reliability, adaptability, and how well each building block supports the goal at hand—be that rapid medicinal chemistry, advanced materials, or greener processes. As someone who’s navigated the bottlenecks of discovery and scaled up to meet shifting project demands, I see real promise in making thoughtful choices at the earliest stage. Each new molecule, each substitution on that aromatic core, pushes the boundaries of what’s possible, shaping not only today’s workflow but the innovations of tomorrow.